SCHEMBL20139709

SCHEMBL20139709

ON=C[C@H](c1cccnn1)c1ccccc1F

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.38
SLC6A9 P48067 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20139604 0.81 HDAC4 (0.40) HDAC4SLC6A9
SCHEMBL20139680 0.76 HDAC4 (0.39) HDAC4
SCHEMBL21229255 0.72 MAPK9 (0.37)
SCHEMBL17316873 0.70 HDAC4 (0.49) HDAC4SLC6A9
SCHEMBL20141623 0.69 HDAC4 (0.37) HDAC4SLC6A9
SCHEMBL5071497 0.62 NFE2L2 (0.38) HDAC4
SCHEMBL7640862 0.61 KDM4E (0.39) SLC6A9
SCHEMBL31092428 0.60
SCHEMBL4269628 0.60
SCHEMBL3293490 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538520-A2 SGC STIMULATORS Cyclerion Therapeutics, Inc. (US) 2019-09-18 EP disclosed
WO-2018089330-A2 SGC STIMULATORS IRONWOOD PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed